Silent mutations in the phenylalanine hydroxylase gene as an aid to the diagnosis of phenylketonuria

15Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

Direct sequencing of the phenylalanine hydroxylase (PAH) gene indicated the existence of silent mutations in codons 232, 245, and 385, linked to specific RFLP haplotypes in several Caucasian populations, namely Germans, Bulgarians, Italians, Turks, and Lithuanians. All three mutations create a new restriction site and can be easily detected on PCR amplified DNA. The usefulness of the silent mutations for diagnostic purposes depends on the haplotype distribution in the target population. The combined analysis of these markers and one or two PKU mutations forms a simple panel of diagnostic tests with full informativeness in a large proportion of PKU families, which helps to avoid the problems of genetic heterogeneity and of prenatal genomic Southern blot analysis.

Cite

CITATION STYLE

APA

Kalaydjieva, L., Dworniczak, B., Aulehla-Scholz, C., Devoto, M., Romeo, G., Sturhmann, M., … Horst, J. (1991). Silent mutations in the phenylalanine hydroxylase gene as an aid to the diagnosis of phenylketonuria. Journal of Medical Genetics, 28(10), 686–690. https://doi.org/10.1136/jmg.28.10.686

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free